Improving Property Tax Management to Optimize Local Government Revenues

whitePaper | March 14, 2022

Appian Government Cloud (AGC) is a cloud service offering with a DISA Provisional Authorization (PA) at Impact Level 5 (IL5). US Department of Defense Mission Owners can leverage the AGC PA to reduce their security responsibilities and accelerate their Authority to Operate (ATO) for cloud applications. Applications deployed on AGC are built using the Appian Low-Code Platform

whitePaper | January 11, 2020

For the first time, in 2020, we see the focus on the “E” and the “S” of environment, social and governance (ESG) as the leading trend globally, including in the United States, where it traditionally has not received as much attention by boards. Indeed, many of the key global trends for 2020, such as board oversight of human capital management (HCM), can be seen as subsets of ESG.

whitePaper | April 6, 2020

Government agencies are at an important crossroads. For years they’ve faced mandates to modernize IT, but many have made limited progress. Now, with increasing citizen demands and other mission requirements, agencies are under pressure to adopt newer technologies. Faced with aging systems that are not up to the task — along with the need to reduce security risks and improve efficiencies — cloud is emerging as the primary vehicle for transforming government agencies.

whitePaper | September 19, 2022

Sophos' annual study of the real-world ransomware experiences of IT professionals in the state and local government sector has revealed an ever more challenging attack environment. Together with the growing financial and operational burden ransomware places on its victims, it also shines new light on the relationship between ransomware and cyber insurance - including how insurance drives changes to cyber defenses.

whitePaper | December 26, 2019

Transforming the way governments serve the public is about more than choosing the right technologies. This level of change requires agencies to rethink how they engage their customers — from citizens and external partners to the frontline employees assisting the public.

whitePaper | December 10, 2019

The Trump administration, members of Congress from both parties, and many states have introduced proposals to combat high drug prices. Too often missing from these reform efforts, however, is a clear understanding of a root cause of the crisis: the suppression of fair market competition through various forms of monopoly. This white paper examines and proposes solutions for the two main ways that monopoly drives up the costs and lowers the quality of prescription drugs: increasing corporate concentration in the pharmaceutical industry, and the monopoly markets for individual drugs created by a deeply flawed and increasingly abused patent and regulatory system.